{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:46:24Z","timestamp":1761561984120},"reference-count":19,"publisher":"Japanese Circulation Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1253\/circj.cj-15-0396","type":"journal-article","created":{"date-parts":[[2015,5,10]],"date-time":"2015-05-10T22:04:02Z","timestamp":1431295442000},"page":"1193-1198","source":"Crossref","is-referenced-by-count":4,"title":["Report of the American College of Cardiology (ACC) Scientific Sessions 2015, San Diego"],"prefix":"10.1253","volume":"79","author":[{"given":"Toyoaki","family":"Murohara","sequence":"first","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kusunose K. Report of the American College of Cardiology (ACC) Scientific Sessions 2014, Washington, DC. <i>Circ J<\/i> 2014; 78: 1311\u20131316.","DOI":"10.1253\/circj.CJ-14-0411"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Douglas PS, Hoffmann U, Patel MR, Mark DB, Al-Khalidi HR, Cavanaugh B, et al; PROMISE Investigators. Outcomes of anatomical versus functional testing or coronary artery disease. <i>N Engl J Med<\/i> 2015; 372: 1291\u20131300.","DOI":"10.1056\/NEJMoa1415516"},{"key":"3","unstructured":"3. Yasue H, Omote S, Takizawa A, Nagao M. Coronary arterial spasm in ischemic heart disease and its pathogenesis: A review. <i>Circ Res<\/i> 1983; 52: I147\u2013I152."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: Differences between Japanese and Caucasian patients. <i>J Am Coll Cardiol<\/i> 1999; 33: 1442\u20131452.","DOI":"10.1016\/S0735-1097(99)00073-X"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J, et al. Long-term prognosis for patients with variant angina and influential factors. <i>Circulation<\/i> 1988; 78: 1\u20139.","DOI":"10.1161\/01.CIR.78.1.1"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, et al; PARTNER 1 trial investigators. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): A randomised controlled trial. <i>Lancet<\/i>2015 March 15, doi:10.1016\/S0140-6736(15)60308-7.","DOI":"10.1016\/S0140-6736(15)60308-7"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, et al; PARTNER trial investigators. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): A randomised controlled trial. <i>Lancet<\/i>2015 March 15, doi:10.1016\/S0140-6736(15)60290-2.","DOI":"10.1016\/S0140-6736(15)60290-2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sawa Y, Saito S, Kobayashi J, Niinami H, Kuratani T, Maeda K, et al; MDT-2111 Japan Investigators. First clinical trial of a self-expandable transcatheter heart valve in Japan in patients with symptomatic severe aortic stenosis. <i>Circ J<\/i> 2014; 78: 1083\u20131090.","DOI":"10.1253\/circj.CJ-14-0162"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Fuku Y, Goto T, Komiya T, Sakaguchi G, Shimamoto T, Maruo T, et al. Thirty-day outcome of transcatheter aortic valve implantation with the Edwards SAPIEN XT prosthesis via the trans-iliofemoral approach. <i>Circ J<\/i> 2014; 78: 1357\u20131363.","DOI":"10.1253\/circj.CJ-13-1220"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Maeda K, Kuratani T, Torikai K, Mizote I, Ichibori Y, Onishi T, et al. New self-expanding transcatheter aortic valve device for transfemoral implantation: Early results of the first-in-Asia implantation of the ACURATE Neo\/TF<sup>TM<\/sup> system. <i>Circ J<\/i> 2015; 79: 1037\u20131043.","DOI":"10.1253\/circj.CJ-14-1110"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Matsumoto T, Kar S. Latest advances in transseptal structural heart interventions: Percutaneous mitral valve repair and left atrial appendage occlusion. <i>Circ J<\/i> 2014; 78: 1782\u20131790.","DOI":"10.1253\/circj.CJ-14-0681"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Abifadel M, Varret M, Rab\u00e8s JP, Allard D, Ouguerram K, Devillers M, et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. <i>Nat Genet<\/i> 2003; 34: 154\u2013156.","DOI":"10.1038\/ng1161"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Sabatine MS, Giugliano RP, Wiviott SD, Raal FJ, Blom DJ, Robinson J, et al; Open-Label Study of Long-Term Evaluation against LDL Cholesterol (OSLER) Investigators. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. <i>N Engl J Med<\/i>2015 March 15, doi:10.1056\/NEJMoa1500858.","DOI":"10.1056\/NEJMoa1500858"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, et al; ODYSSEY LONG TERM Investigators. Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. <i>N Engl J Med<\/i>2015 March 15, doi:10.1056\/NEJMoa1501031.","DOI":"10.1056\/NEJMoa1501031"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hirayama A, Honarpour N, Yoshida M, Yamashita S, Huang F, Wasserman SM, et al. Effects of evolocumab (AMG 145), a monoclonal antibody to PCSK9, in hypercholesterolemic, statin-treated Japanese patients at high cardiovascular risk: Primary results from the phase 2 YUKAWA study. <i>Circ J<\/i> 2014; 78: 1073\u20131082.","DOI":"10.1253\/circj.CJ-14-0130"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Park SJ, Ahn JM, Kim YH, Park DW, Yun SC, Lee JY, et al; BEST Trial Investigators. Trial of everolimus-eluting stents or bypass surgery for coronary disease. <i>N Engl J Med<\/i> 2015; 372: 1204\u20131212.","DOI":"10.1056\/NEJMoa1415447"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Bangalore S, Guo Y, Samadashvili Z, Blecker S, Xu J, Hannan EL. Everolimus-eluting stents or bypass surgery for multivessel coronary disease. <i>N Engl J Med<\/i> 2015; 372: 1213\u20131222.","DOI":"10.1056\/NEJMoa1412168"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kohno T. Report of the American Heart Association (AHA) Scientific Sessions 2014, Chicago. <i>Circ J<\/i> 2014; 79: 34\u201340.","DOI":"10.1253\/circj.CJ-14-1329"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Muramatsu T, Ozaki Y. European Society of Cardiology (ESC) congress report from Barcelona 2014. <i>Circ J<\/i> 2014; 78: 2610\u20132618.","DOI":"10.1253\/circj.CJ-14-1088"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/79\/6\/79_CJ-15-0396\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T21:58:21Z","timestamp":1566683901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/79\/6\/79_CJ-15-0396\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-15-0396","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}